Clinical Trials Directory

Trials / Unknown

UnknownNCT00723268

Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Mashhad University of Medical Sciences · Academic / Other
Sex
All
Age
15 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether low doses of prednisolone, or colchicine are effective in the treatment of oral aphthae.

Detailed description

Treatment of recurrent aphthous stomatitis (RAS) remains, to date, empirical and non-specific. The main goals of therapy are to minimize pain and functional disabilities as well as decrease inflammatory reactions and frequency of recurrences.

Conditions

Interventions

TypeNameDescription
DRUGPrednisolone5MG Prednisolone per day for 3 months
DRUGColchicine0.5 MG Colchicine per day for 3 months

Timeline

Start date
2007-05-01
Primary completion
2008-08-01
First posted
2008-07-28
Last updated
2008-07-29

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT00723268. Inclusion in this directory is not an endorsement.

Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae (NCT00723268) · Clinical Trials Directory